TLDR Classover embraces Solana for payments and staking, boosting blockchain reach. KIDZ stock pops as Classover integrates Solana payments and staking rewards. Solana joins Classover’s edtech platform for fast payments and staking perks. Classover adopts SOL payments, launches validator node, and grows treasury. Blockchain meets K-12: Classover adds Solana payments, staking, and reserves. Classover Holdings, [...] The post Classover Holdings (KIDZ) Stock: Surges on SOL Payment Rollout and Validator Staking Push appeared first on CoinCentral.TLDR Classover embraces Solana for payments and staking, boosting blockchain reach. KIDZ stock pops as Classover integrates Solana payments and staking rewards. Solana joins Classover’s edtech platform for fast payments and staking perks. Classover adopts SOL payments, launches validator node, and grows treasury. Blockchain meets K-12: Classover adds Solana payments, staking, and reserves. Classover Holdings, [...] The post Classover Holdings (KIDZ) Stock: Surges on SOL Payment Rollout and Validator Staking Push appeared first on CoinCentral.

Classover Holdings (KIDZ) Stock: Surges on SOL Payment Rollout and Validator Staking Push

2025/10/04 00:28
3 min read

TLDR

  • Classover embraces Solana for payments and staking, boosting blockchain reach.
  • KIDZ stock pops as Classover integrates Solana payments and staking rewards.
  • Solana joins Classover’s edtech platform for fast payments and staking perks.
  • Classover adopts SOL payments, launches validator node, and grows treasury.
  • Blockchain meets K-12: Classover adds Solana payments, staking, and reserves.

Classover Holdings, Inc. (KIDZ) shares opened sharply higher and surged past $1.60 before stabilizing near $1.24 in afternoon trading.

Classover Holdings, Inc. (KIDZ)

The rally followed the company’s announcement regarding the integration of Solana (SOL) as a payment method and blockchain engagement initiative. Despite the pullback from the intraday high, the stock remains up nearly 10% on the day.

Solana Accepted as Payment for Educational Services

Classover Holdings began accepting Solana (SOL) as a direct payment method across its educational platform this week. This development makes Classover one of the first Nasdaq-listed companies to implement Solana for real-time user payments. The company aims to offer faster transaction processing and lower costs compared to traditional systems.

Management expects this move to attract users seeking flexible payment options and improve platform efficiency. In parallel, the initiative expands Classover’s exposure to digital assets without altering its core educational service model. The company integrated SOL payments through a seamless checkout experience for both new and existing users.

Classover aligns its tech infrastructure with blockchain adoption trends in consumer markets. The integration also supports its long-term vision of leveraging digital assets in mainstream commerce. The rollout further strengthens Classover’s competitive position in the K-12 edtech sector.

SOL Validator Node Launch and Staking Incentives

Classover introduced a branded validator node on the Solana network to encourage user engagement. The company launched a staking campaign aimed at its user base, offering lesson credit incentives tied to SOL delegation. Participants who stake SOL with Classover’s validator will receive rewards along with bonus educational credits.

This move creates a dual incentive system, combining blockchain-based staking benefits with tangible learning rewards. The staking initiative also promotes decentralization by supporting Solana’s network infrastructure. Through this campaign, Classover aims to enhance long-term user retention and blockchain adoption.

The staking mechanism marks a strategic expansion of the firm’s blockchain engagement strategy. With this launch, Classover deepens its role not just as a payment facilitator but also as a network contributor. It positions the company at the intersection of fintech innovation and educational utility.

SOL Treasury Strategy and Market Outlook

Classover confirmed it holds 57,793 SOL in its treasury, valued at approximately $13.4 million USD. The company has not sold any of its SOL holdings, reinforcing a strategy centered on long-term accumulation and digital asset preservation. This reflects confidence in the value and stability of the Solana ecosystem.

Classover’s treasury allocation aligns with its commitment to integrate blockchain across operational, transactional, and reserve functions. The retained SOL also strengthens the company’s liquidity position while reinforcing its blockchain credibility. By building a SOL-based reserve, Classover underscores its commitment to digital assets as a key component of modern corporate strategy.

The company’s blockchain-forward initiatives drove renewed interest in KIDZ shares during Thursday’s session. With product rollouts now live, the focus will shift to adoption metrics and ecosystem growth. Classover’s strategy signals an aggressive push toward blending Web3 tools with core educational services.

 

The post Classover Holdings (KIDZ) Stock: Surges on SOL Payment Rollout and Validator Staking Push appeared first on CoinCentral.

Market Opportunity
Solana Logo
Solana Price(SOL)
$84.33
$84.33$84.33
-1.12%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26